Retina-directed gene therapy: Achievements and remaining challenges
Open Access
- 21 April 2025
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 271, 108862
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation
This publication has 283 references indexed in Scilit:
- Progress and Perspective of CRISPR‐Cas9 Technology in Translational MedicineAdvanced Science, 2023
- Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene VariationsJAMA Ophthalmology, 2023
- Optimized Subretinal Injection Technique for Gene Therapy Approaches2018
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola VaccinesJAMA, 2016
- Optimized Technique for Subretinal Injections in Mice2012
- Modification and Labeling of AAV Vector Particles2011
- Novel AAV serotypes for improved ocular gene transferThe Journal of Gene Medicine, 2008
- Development of photoreceptor‐specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptorsThe Journal of Gene Medicine, 2007
- Viral serotype and the transgene sequence influence overlapping adeno‐associated viral (AAV) vector‐mediated gene transfer in skeletal muscleThe Journal of Gene Medicine, 2005
- Expanding AAV Packaging Capacity with Trans-splicing or Overlapping Vectors: A Quantitative ComparisonMolecular Therapy, 2001